Logo 202 Logo 202 (Methylphenidate hydrochloride extended-release 40 mg)
Pill imprint Logo 202 Logo 202 has been identified as Methylphenidate hydrochloride extended-release 40 mg.
Methylphenidate is used in the treatment of adhd; narcolepsy; obesity; depression; fatigue (and more), and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 40 mg has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.
See also related documents.
Images for Logo 202 Logo 202 (Methylphenidate hydrochloride extended-release 40 mg)
More about methylphenidate
- Methylphenidate chewable tablets
- Methylphenidate controlled-release capsules
- Methylphenidate controlled-release tablets
- Methylphenidate extended-release capsules
- More (7) »